A Study to Look at the Safety and the Immune Response to Candidates Against Pneumococcus Bacteria
A Study to Look at the Safety and the Immune Response to Candidates Against Pneumococcus Bacteria. A Phase 1, Randomized, Open-Label Trial to Evaluate the Safety and Immunogenicity of
Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age.
Category & Conditions: Vaccine-related Conditions
Medicine: PF-07831695
ClinicalTrials.gov Identifier (NCT): NCT05489328
Protocol ID: C4801001
PrintDownloadOpen Plain Language Summary Result: Click here